MONOCLONAL ANTIBODY TO PD-L1

The present invention relates to the field of biotechnology and provides antibodies that specifically binds to PD-L1. The invention also relates to DNA encoding said antibodies, to corresponding expression vectors and to methods of producing, and to methods of treatment using said antibodies.

Saved in:
Bibliographic Details
Main Authors USTIUGOV, Iakov Iurevich, NEMANKIN, Timofey Aleksandrovich, SOLOVYEV, Valery Vladimirovich, AGEEV, Sergei Andreevich, CHERNYKH, Yulia Sergeevna, SOFRONOVA, Ekaterina Vladimirovna, ULITIN, Andrei Borisovich, IAKOVLEV, Pavel Andreevich, EKIMOVA, Viktoriia Mikhailovna, MOROZOV, Dmitry Valentinovich, ALEKSANDROV, Aleksei Aleksandrovich, VLADIMIROVA, Anna Konstantinovna, GREBNEV, Pavel Alekseevich
Format Patent
LanguageEnglish
French
German
Published 26.02.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of biotechnology and provides antibodies that specifically binds to PD-L1. The invention also relates to DNA encoding said antibodies, to corresponding expression vectors and to methods of producing, and to methods of treatment using said antibodies.
Bibliography:Application Number: EP20180786945